A proton beam is a form of focused radiation used to treat solid tumors. It is superior to traditional radiation therapy (X-Ray, or Photons) in that it reduces damage to surrounding healthy tissue by 2X-6X, thereby reducing toxicities and improving patient survival and quality of life. Proton therapy is used routinely for treating many types of cancer; it is FDA-cleared (510k) and reimbursed by both public and private insurers – around the world.
Proton beam therapy can help over one million cancer patients every year globally – yet only 35,000 receive it; that’s less than 5%.
Protons are arguably the most advanced form of radiation therapy – yet there are only 238 proton-therapy centers world-wide; compare with over 10,000 (traditional X-Ray/Gamma) radiation therapy machines.
The main barrier to widespread adoption is the large size (football stadium) and high cost ($150-250M) of building and operating a center. Single-room solutions have been introduced to the market in recent years – yet, at $30-40M per room, they remain prohibitively expensive for the vast majority of hospitals and clinics.
The key to making protons available to every patient is a scalable, add-on, single-room solution, at less than half the current price tag; all while maintaining very high beam quality and providing cutting-edge clinical capabilities such as PBS, IMPT, and more.
HIL’s technological breakthrough promises to bring about this revolution.